FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form Is a Type of drug preparation false Inferred relationship Existential restriction modifier
    Cutaneous AND/OR transdermal dosage form Is a Dose form by site prepared for false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Transiderm-Nitro 5 transdermal patches (Novartis Pharmaceuticals UK Ltd) 28 patch Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nitro-Dur 0.2mg/hour transdermal patches (Organon Pharma (UK) Ltd) 28 patch Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Deponit 5 transdermal patches (Forum Health Products Ltd) 28 patch Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Minitran 10 transdermal patches (Viatris UK Healthcare Ltd) 30 patch Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Transiderm-Nitro 10 transdermal patches (Novartis Pharmaceuticals UK Ltd) 28 patch Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nitro-Dur 0.4mg/hour transdermal patches (Organon Pharma (UK) Ltd) 28 patch Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Deponit 10 transdermal patches (Forum Health Products Ltd) 28 patch Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (A A H Pharmaceuticals Ltd) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (A A H Pharmaceuticals Ltd) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Candiden 1% cream (Akita Pharmaceuticals) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Alpharma Limited) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Approved Prescription Services) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Abtrim 1% cream (Ashbourne Pharmaceuticals Ltd) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Canesten 1% cream (Bayer Plc) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Canesten 1% cream (Bayer Plc) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Canesten AF 1% cream (Bayer Plc) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Viatris UK Healthcare Ltd) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Kent Pharma (UK) Ltd) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Kent Pharma (UK) Ltd) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fungederm 1% cream (Nucare Plc) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Thornton & Ross Ltd) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Unichem Plc) 20 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Unichem Plc) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Canesten Dermatological 1% powder (Bayer Plc) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Canesten AF 1% powder (Bayer Plc) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Propaderm 0.025% cream (GlaxoSmithKline) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Propaderm 0.025% ointment (GlaxoSmithKline) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betnovate RD 0.025% ointment (GlaxoSmithKline) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Movelat gel (Sankyo Pharma UK) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Movelat Relief gel (Sankyo Pharma UK) 40 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Movelat Relief gel (Sankyo Pharma UK) 80 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eumovate 0.05% cream (GlaxoSmithKline) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eumovate 0.05% cream (GlaxoSmithKline) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eumovate Eczema and Dermatitis 0.05% cream (Haleon UK Ltd) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eumovate 0.05% ointment (GlaxoSmithKline) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eumovate 0.05% ointment (GlaxoSmithKline) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Intralgin gel (3M Health Care Ltd, Pharmaceuticals Division) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (A A H Pharmaceuticals Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (A A H Pharmaceuticals Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (A A H Pharmaceuticals Ltd) 4.5 kg Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Adams Healthcare) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Adams Healthcare) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Alpharma Limited) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Approved Prescription Services) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (The Boots Company) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Kent Pharma (UK) Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Sandoz Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (J M Loveridge Plc) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Thornton & Ross Ltd) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Thornton & Ross Ltd) 4.5 kg Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Unichem Plc) 500 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dermovate 0.05% cream (GlaxoSmithKline) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dermovate 0.05% cream (GlaxoSmithKline) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dermovate 0.05% ointment (GlaxoSmithKline) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dermovate 0.05% ointment (GlaxoSmithKline) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Difflam 3% cream (Viatris UK Healthcare Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Difflam-P 3% cream (Viatris UK Healthcare Ltd) 35 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Diprosalic 0.05%/3% ointment (Organon Pharma (UK) Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Diprosalic 0.05%/3% ointment (Organon Pharma (UK) Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fucibet cream (LEO Pharma) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fucibet cream (LEO Pharma) 60 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Drapolene cream (Pfizer Consumer Healthcare) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Drapolene cream (Pfizer Consumer Healthcare) 200 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Drapolene cream (Pfizer Consumer Healthcare) 350 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Skinoren 20% cream (LEO Pharma) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Daktacort ointment (Janssen-Cilag Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Daktacort cream (Janssen-Cilag Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Daktacort HC cream (McNeil Ltd) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Differin 0.1% gel (Galderma (UK) Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Differin 0.1% cream (Galderma (UK) Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Cuplex gel (Crawford Pharmaceuticals) 5 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Cutivate 0.05% cream (GlaxoSmithKline) 15 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Cutivate 0.05% cream (GlaxoSmithKline) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Traxam 3% gel (Goldshield Healthcare Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Traxam Pain Relief 3% gel (Goldshield Healthcare Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elocon 0.1% cream (Organon Pharma (UK) Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elocon 0.1% cream (Organon Pharma (UK) Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elocon 0.1% ointment (Organon Pharma (UK) Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elocon 0.1% ointment (Organon Pharma (UK) Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar 0.025% gel (GP Pharma) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar 0.025% cream (GP Pharma) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar 0.025% cream (GP Pharma) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar 0.025% ointment (GP Pharma) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar 0.025% ointment (GP Pharma) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar 1 in 4 Dilution 0.00625% cream (GP Pharma) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Locoid 0.1% ointment (Neon Healthcare Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Locoid 0.1% ointment (Neon Healthcare Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Vectavir Cold Sore 1% cream (Novartis Consumer Health UK Ltd) 2 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.1% cream (A A H Pharmaceuticals Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betnovate 0.1% cream (GlaxoSmithKline) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betnovate 0.1% cream (GlaxoSmithKline) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.1% cream (Kent Pharma (UK) Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.1% cream (Unichem Plc) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betnovate RD 0.025% cream (GlaxoSmithKline) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Movelat Relief cream (Sankyo Pharma UK) 40 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Movelat Relief cream (Sankyo Pharma UK) 80 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Movelat cream (Sankyo Pharma UK) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Proflex 5% cream (Novartis Consumer Health UK Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Proflex Pain Relief 5% cream (Novartis Consumer Health UK Ltd) 30 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuprofen 5% gel (A A H Pharmaceuticals Ltd) 50 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuprofen 5% gel (A A H Pharmaceuticals Ltd) 100 gram Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier

    Start Previous Page 28 of 55 Next End


    This concept is not in any reference sets

    Back to Start